Canadian producer Aurora Cannabis has delivered its first flower product in Germany’s growing medical marijuana market.
The Island Sweet Skunk sativa strain, which contains 20% THC, was produced under the Alberta-based company’s newly formed IndiMed brand, according to a news release.
ADVERTISEMENT
“Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product – a significant step forward since Germany’s move to decriminalize cannabis earlier this year,” Aurora Europe President Michael Simon said in a statement.
The company’s European Union-Good Manufacturing Practice (GMP)-certified facility in Leuna, Germany, is one of only three licensed to cultivate marijuana in the country, he added.
Aurora is the latest Canadian cannabis operator to move into Germany after the European nation
Read full article on Marijuana Business Daily
